In line with the Facilities for Illness Management and Prevention, greater than 37 million folks within the U.S. have diabetes. That is a bit of greater than 11% of your complete inhabitants.
A diabetic’s physique would not make sufficient or any insulin in any respect. These with the illness should frequently monitor their blood sugar. This has been historically accomplished with glucometers, which diabetics use to prick their fingers time and again for drops of blood. However during the last decade, know-how like steady glucose monitoring has been on the rise.
Abbott and Dexcom are the 2 most dominant gamers within the area. Each firms have seen elevated development.
The know-how can also be being marketed by a number of well being and wellness apps as many firms see advantages for many who do not have diabetes.
CNBC spoke with each Abbott and Dexcom in regards to the know-how inside CGMs and the way they see it increasing.